Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Diabetes Reports|March 20, 2003
Endothelial dysfunction in human diabetesSari Mäkimattila, Hannele Yki-Järvinen
The Lancet Regional Health. Europe|March 27, 2024
Incidence and risk factors for cancer in people with type 1 diabetes, stratified by stages of diabetic kidney disease: a nationwide Finnish cohort studyMaija Feodoroff, Valma Harjutsalo, Sari Mäkimattila, et al.
Diabetes Care|March 7, 2020
Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide StudySari Mäkimattila, Valma Harjutsalo, Carol Forsblom, et al.
Journal of the Endocrine Society|April 1, 2024
Risk of Thyroid Cancer in People With Type 1 Diabetes by Autoimmune Thyroid Diseases and Tumor HistologySari Mäkimattila, Valma Harjutsalo, Maija Feodoroff, et al.
Journal of Diabetes and Its Complications|April 24, 2016
Dietary patterns are associated with various vascular health markers and complications in type 1 diabetesAila J Ahola, Riitta Freese, Sari Mäkimattila, et al.
Pharmacoepidemiology and Drug Safety|October 24, 2013
Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage studyJari Haukka, Fabian Hoti, Panu Erästö, et al.
Cerebellum (London, England)|March 27, 2010
Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetesOuti Heikkilä, Sari Mäkimattila, Marjut Timonen, et al.
Metabolic Brain Disease|July 24, 2008
Risk for metabolic syndrome predisposes to alterations in the thalamic metabolismOuti Heikkilä, Nina Lundbom, Marjut Timonen, et al.
Metabolic Brain Disease|April 29, 2010
Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes--a 1H MRS studyOuti Heikkilä, Nina Lundbom, Marjut Timonen, et al.
Diabetes Research and Clinical Practice|February 27, 2017
Association between adherence to dietary recommendations and high-sensitivity C-reactive protein level in type 1 diabetesAila J Ahola, Markku Saraheimo, Riitta Freese, et al.
Pageof 3